Sino Biological finalizes the acquisition of SignalChem Biotech, strengthening global presence and expanding product portfolio

FHS
April 29, 2024
11:56 am

Evaluating allogeneic transplant for TP53 mutated acute myeloid leukemia

A new editorial was published in Oncotarget’s Volume 15 on October 1, 2024, entitled, “Transplant or no transplant for TP53 mutated AML.”

October 12, 2024

Sosei and PharmEnable collaborate on another neurological drug – Pharmaceutical Technology

As per the agreement, both companies are sharing the discovery and development costs. The companies will also co-own the drugs developed during their partnership. Image

October 10, 2023

The new science behind the health benefits of caffeine

A study reveals caffeine’s potential to enhance heart health by improving endothelial function in systemic lupus erythematosus patients through EPC survival.

October 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.